Tag: Department of Health and Social Care

  • PRESS RELEASE : Government offer to NHS consultants to pave way to end strikes [November 2023]

    PRESS RELEASE : Government offer to NHS consultants to pave way to end strikes [November 2023]

    The press release issued by the Department of Health and Social Care on 27 November 2023.

    The offer will invest in modernising the consultants’ pay structure – reducing the number of pay points and the time it takes to reach the top.

    • The government has put forward an offer that will modernise the consultant contract and reform consultants’ pay structure
    • The British Medical Association and Hospital Consultants and Specialists Association will put the deal to their memberships
    • Agreement by union members would see the end of consultant strike action – benefiting patients and helping to cut waiting lists

    The government and unions representing consultant doctors in England have reached an agreement to put an offer to union members following constructive negotiations.

    Talks were opened with the British Medical Association (BMA) and Hospital Consultants and Specialists Association (HCSA) last month to find a fair and reasonable way forward.

    All parties strived to find a fair deal for NHS consultants but also one that acknowledges the wider economic pressures facing the UK and the need to continue to bring down inflation.

    The government was clear that the headline pay uplift for 2023 to 2024 was settled through the pay review body process. This offer builds on that and focuses on measures that will address consultant concerns while introducing contractual reforms. The core contract for consultants has not been updated for 20 years and this offer will modernise it, including through offering enhanced shared parental leave, in line with other NHS staff.

    The offer will invest in modernising the consultants’ pay structure – reducing the number of pay points and the time it takes to reach the top, taking effect from January 2024.

    New pay progression arrangements will be introduced to ensure there is a clearer link between pay progression and evidence of skills, competencies and experience.

    The BMA and HCSA will put this offer to their members for a vote in the coming weeks. No further strike action will be called while members are being consulted.

    Prime Minister Rishi Sunak said:

    Ending damaging strike action in the NHS is vitally important if we want to continue making progress towards cutting waiting lists while making sure patients get the care they deserve.

    This is a fair deal for consultants who will benefit from major reform to their contract, it is fair for taxpayers because it will not risk our ongoing work to tackle inflation, and most importantly it is a good deal for patients to see the end of consultant industrial action.

    Health and Social Care Secretary Victoria Atkins said:

    I hugely value the work of NHS consultants and am pleased that we have been able to make this fair and reasonable offer after weeks of constructive negotiations.

    If accepted, it will modernise pay structures, directly addressing gender pay issues in the NHS. It will also enhance consultants’ parental leave options.

    Putting an end to this strike action will support our efforts to bring down waiting lists and offer patients the highest quality care.

    The pay scale reforms will also help mitigate the gender pay gap by delivering a key recommendation made by Professor Dame Jane Dacre in her review on the gender pay gap in medicine. To enable these reforms, unions have agreed to end Local Clinical Excellence Awards (LCEAs) going forward – an employer-level bonus scheme – which has been seen to contribute to pay inequalities.

    Alongside this, consultants will also be entitled to enhanced shared parental leave, bringing them in line with other NHS staff.

    As part of this offer, the government and unions have agreed to work together to review the operation of the Review Body on Doctors’ and Dentists’ Remuneration (DDRB) – the pay review process for doctors. It will examine the appointments of members to the DDRB, the timing of the round, remit letters and terms of reference, and the data provided to the body on which it bases its recommendations. These changes will be implemented for the 2025 to 2026 pay year.

    As part of this provisional deal, the BMA has also agreed to end the use of its rate card – which advises doctors on how much to charge for non-contractual work, including cover during strikes. Until now, the card has increased the cost of finding shift cover during industrial action.

    This reform package is separate from the pay-setting process. It does not affect the 6% pay award consultants received this financial year and it will not interfere with the process for setting pay next year. This is in addition to the significant reforms to pension taxation, the BMA’s number one ask, in the spring budget earlier this year.

    Moving forward, the NHS Long Term Workforce Plan will support the NHS to address existing vacancies and meet the challenges of a growing and ageing population by training, recruiting and retaining hundreds of thousands more staff over the next 15 years – backed by more than £2.4 billion in government investment.

    The government has listened carefully to the concerns of consultants, their representatives and employers – particularly around retention, motivation and morale. This offer has been carefully balanced to meet those concerns but also to ensure value for the taxpayer.

  • PRESS RELEASE : Landmark deal to boost nation’s health and save NHS £14 billion [November 2023]

    PRESS RELEASE : Landmark deal to boost nation’s health and save NHS £14 billion [November 2023]

    The press release issued by the Department of Health and Social Care on 20 November 2023.

    New voluntary scheme for branded medicines pricing, access and growth (VPAG) will boost nation’s health, save NHS £14 billion and support research investment.

    • Deal agreed by government, NHS England and pharmaceutical industry will improve access to cutting-edge treatments for NHS patients, support financial sustainability of the health service and advance UK life sciences sector
    • Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more innovative and pioneering branded medicines
    • Significant industry investment in UK clinical trials, manufacturing and health technology assessments strengthens UK’s global competitiveness

    A landmark deal has been agreed that is set to save the NHS £14 billion over 5 years in medicines costs, enable patients to access the latest lifesaving treatments more consistently and boost the UK’s position as a global superpower in advanced healthcare, technology and clinical research.

    The new deal secures savings for the taxpayer-funded health service that are double those under the current medicine pricing agreement, which expires at the end of this year.

    The agreement will save billions more pounds that can be used to provide the best possible treatment and care for NHS patients, grow the workforce and cut waiting lists – one of the Prime Minister’s 5 priorities.

    The voluntary scheme for branded medicines pricing, access and growth (VPAG) has been agreed by the government, NHS England and the Association of the British Pharmaceutical Industry (ABPI) and will run for 5 years until 31 December 2028.

    As well as helping to keep the price of vital branded medicines affordable for the NHS and fair for taxpayers, the deal will help to ensure the NHS can continue to improve the speed it secures and adopts the newest treatments.

    An additional £400 million of life sciences investment by industry will accelerate work on clinical trials, manufacturing and in health technology assessments agencies, encouraging UK economic growth, collaboration and innovation in the sector.

    Health and Social Care Secretary Victoria Atkins said:

    Millions of NHS patients will benefit from this momentous, UK-wide agreement.

    Not only will it save the health service billions of pounds every year, it will allow more patients to quickly access the latest life-saving medicines and treatments.

    This deal will also ensure the UK remains a world leader in driving forward innovative healthcare while boosting our economy, with hundreds of millions of pounds invested in vital research, clinical trials and manufacturing.

    Medicines represent the second highest proportion of NHS spend, worth £19.2 billion in England in the 2022 to 2023 financial year. Fourteen billion pounds of this was branded, with the industry paying the NHS back £2 billion in rebates that year. This agreement, however, sets a yearly cap on the total allowed sales value of branded medicines to the NHS each year. Sales above the cap are paid back to the government via a levy.

    The level of annual allowed growth in sales of branded medicines will double from 2% in 2024 to 4% by 2027.

    The agreement also introduces a new affordability mechanism for older medicines. Older medicines which have not seen price reductions, will have to pay a top-up rate of up to 25% in addition to the older medicines base rate of 10%. The top-up tapers down for older medicines that have already seen significant price reductions, ensuring we recognise when competition has worked effectively to makes savings for the NHS.

    The income from this mechanism will support lower payment rates for more innovative medicines, making the agreement explicitly pro-innovation and pro-competition.

    Chancellor of the Exchequer Jeremy Hunt said:

    This landmark agreement will not only save the NHS money, but help patients get access to the very best medicines and treatments for years to come. With significant new industry investment in research, clinical trials and manufacturing, this deal will bolster Britain’s position as the largest life sciences hub in Europe and support a sector so critical to our country’s health, wealth and resilience.

    Under the agreement which comes into force in 2024, the pharmaceutical industry will also invest £400 million over 5 years through the Life Sciences Investment Programme to drive forward UK innovation, sustainability and growth. The programme will be ringfenced to support work in:

    1. Pioneering clinical trials – bolstering the NHS’s capacity to deliver commercial clinical research.
    2. Manufacturing – positioning the UK at the forefront of sustainable manufacturing by driving innovative advancements in environmental technologies and cultivating strategic partnerships.
    3. Innovative health technology assessments – supporting access to innovative medicines by developing novel approaches to health technology assessment challenges.

    This comes as the government committed to £520 million for life sciences manufacturing to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development.

    The programme will be targeted on improving clinical research, manufacturing and the value assessment of new medicines across the 4 nations and will attract more investment to the UK – delivering a net benefit to the economy overall.

    For over 65 years the government and the pharmaceutical industry have worked together to help manage the affordability of medicines for the NHS and ensure rapid access and uptake of new medicines for patients, while also supporting the UK’s life sciences sector so that it can continue to deliver new innovations and economic growth.

    Robert Kettell, NHS England’s Director of Medicines Negotiation and Managed Access, who led day-to-day negotiations:

    This 5-year agreement will enable NHS England to build on our track record of securing innovative, life-changing treatments for millions of patients across the country at a fair price for taxpayers.

    In leading the negotiations, I was clear that any deal had to enable patients to have rapid access to cutting-edge medicines and incentivise the medical research that will provide the treatments of tomorrow. I am confident this agreement delivers these aims.

    To ensure NHS patients across the country can continue to rapidly access innovative medicines, the new agreement highlights how the government, the NHS and the pharmaceutical industry will commit to piloting new approaches for paying for ground-breaking advanced therapy medicinal products (ATMPs), such as personalised cancer therapies and life-saving ‘one shot’ gene therapies.

    This new approach to ATMPs will build on the NHS track record of using its commercial capabilities to secure cutting-edge treatments for patients and deliver innovative medicines access and uptake programmes.

    Earlier this month, NHS England announced that expanding and accelerating uptake of anticoagulant drugs had prevented 4,000 deaths and an estimated 17,000 strokes over the past 18 months.

    During the period of the current VPAS (voluntary scheme for branded medicines pricing and access) agreement, the NHS has also led the world in the development of commercial incentives to tackle antimicrobial resistance and more recently the world-first rollout of a cancer jab that cuts patient treatment time by 75%, to as little as 7 minutes.

    Richard Torbett, Chief Executive at the ABPI, said:

    This is a tough deal which underlines the essential role innovative medicines and vaccines will play in addressing the health challenges of the future. The industry supports this agreement, despite its restrictions, as it provides important support for patients and the NHS and commits to giving them access to the transformative treatments they need.

    Allowing the sector to grow faster than it has under the previous scheme should increase the UK’s international competitiveness over time. Importantly, it also recognises the pressing need to invest more in building NHS capacity to partner with industry on science and research to support innovation and economic growth.

    The deal includes exciting commitments that will see NHS England establish a data driven approach to the use of medicines across the NHS, ensuring the latest medicines are reaching patients with the highest need as quickly as possible; supporting wider commitments to reduce health inequalities. The development of a local formulary national minimum dataset will provide a tool to address variation in the implementation of NICE guidance to improve equity in access to clinically and cost-effective treatments.

    The agreement also details how NHS England will work with companies to create a new patient support programme (PSP) database to encourage local NHS services to partner with manufacturers and encourage the wider use of novel approaches to patient support post treatment.

  • PRESS RELEASE : Biggest prostate cancer screening trial in decades to start in UK [November 2023]

    PRESS RELEASE : Biggest prostate cancer screening trial in decades to start in UK [November 2023]

    The press release issued by the Department of Health and Social Care on 19 November 2023.

    The trial will use innovative screening methods like an MRI scan and see hundreds of thousands of men across the country participating.

    • On International Men’s Day (19 November 2023), government joins Prostate Cancer UK to unveil £42 million screening trial to find ways of detecting country’s most common male cancer earlier
    • Hundreds of thousands of men across the country will participate, with 1 in 10 participants set to be black men who have a much higher prostate cancer risk
    • NHS England to carry out suite of improvements to men’s health pages online, and first ever Men’s Health Ambassador set to be appointed by government

    Thousands of men’s lives could be saved, and their loved ones spared the tragedy of losing someone to cancer, as a major new prostate cancer screening trial is set to get under way in the UK backed by £42 million from the government and Prostate Cancer UK.

    The first-of-its-kind trial – called TRANSFORM – will use innovative screening methods like an MRI scan to detect prostate cancer, and it will see hundreds of thousands of men across the country participating.

    Prostate cancer is the most common cancer in men in the UK and has no screening programme. It usually has no symptoms until it has grown large and may be more difficult to treat and, sadly, 12,000 men die of it every single year.

    A way of effectively screening for prostate cancer could find these men before their cancer spreads and save their lives.

    The trial has the potential to see new screening methods give more accurate results than the current blood tests, which can miss some cancers and often suggest prostate cancer when no cancer exists.

    Crucially, screening could also spot the disease even when no symptoms are displayed.

    Health and Social Care Secretary Victoria Atkins said:

    Cancer survival rates continue to improve in the UK, with the disease being diagnosed at an earlier stage more often. But more must be done.

    Our hope is that this funding will help to save the lives of thousands more men through advanced screening methods that can catch prostate cancer as early as possible.

    Laura Kerby, Chief Executive at Prostate Cancer UK, said:

    12,000 men die of prostate cancer each year and it’s the most common cancer that doesn’t have a national screening programme.

    It’s about time that changed. That’s why we’re launching our biggest and most ambitious trial ever. It will finally give us the answers we need to develop a routine testing system and save thousands of men each year.

    Prostate Cancer UK’s unique focus and expertise made us the only organisation that could really deliver this paradigm-shifting trial, and we’re delighted that the government has backed our vision to revolutionise diagnosis.

    One in 4 black men will develop prostate cancer – double the risk of other men. Therefore, to ensure the trial helps reduce their risk of dying from this disease, 1 in 10 men invited to participate will be black men. Participating men in the screening trial will be aged 50 to 75, with black men eligible from the lower age range of 45 to 75.

    Men at higher risk of prostate cancer due to age and ethnicity will be recruited through their GP practice and invited to a screening visit.

    More than 52,000 men are diagnosed with prostate cancer every year in the UK on average – that’s 144 men every day. Around 490,000 men are currently living with and after prostate cancer.

    Sports broadcaster Steve Rider, 73, shared his prostate cancer diagnosis last month:

    It was from talking with friends that I explored my risk of prostate cancer. I didn’t have any symptoms and wasn’t expecting to be diagnosed.

    Luckily, my cancer was all contained within the prostate, giving me the opportunity to have significant surgery to deal with it, but for too many men they are diagnosed late.

    £16 million will be invested by the government for the trial through the National Institute for Health and Care Research (NIHR) and Prostate Cancer UK, who have led the development of the trial, will provide £26 million. The trial is due to start in spring 2024 with recruitment likely to begin in autumn 2024.

    The government has already opened 127 community diagnostic centres to offer quicker, more convenient checks outside of hospitals for conditions such as cancer, with over 5 million additional tests delivered so far.

    The major conditions strategy will also consider the prevention, diagnosis, treatment and management of conditions including cancer. The UK is already working with world-renowned scientists to deliver new cancer vaccine trials and is growing the size of the specialist workforce.

    Daniel Burkey, 58, from Yorkshire, was diagnosed with advanced prostate cancer in June 2021. He said:

    Men need prostate cancer screening so that if we’ve got it, we can find out early enough to treat it and get rid of it. I got my diagnosis in my fifties, and the doctor told me the horrible news that it can’t be cured.

    It was an awful shock, and I still find it hard to accept that I’ll always have this disease, but I’m doing everything I can to control the cancer with chemotherapy, radiotherapy and 2 kinds of hormone therapy; one by injection, one orally.

    Things could have been different if I’d been tested routinely and caught it early enough. If the UK gets prostate cancer screening, so many lives will be saved. Knowing that this trial is going to find a way to do that makes me optimistic for other men.

    Professor Lucy Chappell, NIHR Chief Executive, said:

    New research into harnessing innovative screening methods is crucial in finding ways to detect this serious disease earlier, in the race against time to save lives.

    That’s why setting up this landmark new trial in partnership between NIHR and Prostate Cancer UK is so important.

    Together we can aim to generate high quality long-term evidence to benefit men at risk of developing this condition, and to inform those who plan and deliver NHS services of how best to test for the disease.

    Other measures announced today

    Men’s Health Ambassador

    The government will be recruiting for the UK’s first ever Men’s Health Ambassador, we are inviting applications from anyone with an interest and expertise in men’s health.

    The successful candidate, to be announced in the coming months, will be responsible for increasing awareness of certain conditions and health needs faced by men. They will help dispel taboos and stigmas and encourage more open conversations among men about their general health.

    The role will be open for applications on GOV.UK shortly.

    NHS website updates

    NHS England will deliver a host of important improvements and updates to pages on its website most used by men.  This will make it easier for men to both find and understand the help and support on offer for certain conditions.

    Pages on issues like prostatitis, testicular cancer and low sperm count will be updated in the coming months.

    Men’s health task and finish group

    The government will establish the first men’s health task and finish group. Membership will include behavioural scientists, men’s health campaigners, experts and academics.

    Together, they will help us identify how we can get more men to engage with their health, including a focus on better understanding male access to primary care services, such as GPs and male uptake of the NHS Health Check.

  • PRESS RELEASE : New NIHR Research Delivery Network created [November 2023]

    PRESS RELEASE : New NIHR Research Delivery Network created [November 2023]

    The press release issued by the Department of Health and Social Care on 14 November 2023.

    The network will play a critical and active role in supporting the health and care research system to bring innovative new treatments and care to patients, carers and the public.

    The new National Institute for Health and Care Research – Research Delivery Network (NIHR RDN) will commence in 2024 to support the successful delivery of health and social care research in England. It will take over from NIHR – Clinical Research Network (NIHR CRN) building on its successes, including the remarkable efforts made during the COVID-19 pandemic and the subsequent recovery of the research system.

    The Department of Health and Social Care (DHSC) has designated the University of Leeds as the single host of the new NIHR RDN Co-ordinating Centre (RDNCC) from 1 April 2024. This contract has been awarded following a commercial procurement exercise.

    From October 2024, they will be joined by 12 Regional Research Delivery Networks (RRDNs), hosted by NHS organisations the length and breadth of the country, to make up the NIHR RDN.

    The network will operate as one organisation across England and will play a critical and active role in implementing government policy, including:

    NIHR RDN will be a new organisation with new processes, structures and governance, working to ensure co-ordination and support through a consistent, customer-focused approach. It will increase capacity and capability across the health and care research system, supporting the successful delivery of high-quality research across England for the benefit of patients and the public. It represents a significant government investment to bolster the UK’s position as one of the best places in the world for innovative companies and investigators to carry out research.

    It will work across the health and care system, with staff in all health and care settings, to support the effective and efficient initiation and delivery of research. This will benefit people receiving care now and in the future, support the NHS and social care services and generate benefits for the economy of the UK.

    Growing the amount of commercial clinical research will be a key strategic ambition for the new network. This follows the publication of the review into commercial clinical trials by Lord O’Shaughnessy in May 2023 which set out a clear blueprint for how the UK can return to its global leadership role. The government will shortly be responding to the review in full.

    The network will focus on portfolio monitoring, identifying and resolving strategic challenges to ensure the research system is able to achieve its ambitions around innovative study methodology, increasing the diversity of populations taking part in research and broadening the settings in which research takes place. Research funders, sponsors and sites will remain responsible for the delivery of individual studies.

    It will provide funding to study sites that can be used to support the costs of research delivery across the entire study delivery pathway. It will provide financial oversight to ensure this funding is being used to support research and development activities and provide dedicated support to ensure study sites are recovering all appropriate costs to sustainably fund and grow research delivery staff and facilities.

    The network will provide an enhanced study support service which will facilitate smoother, interconnected access to research infrastructure for the life sciences industry and researchers. The expertise and site-level intelligence of staff from RRDNs will be drawn together with the national oversight and leadership of the RDNCC to provide a more effective end-to-end service for customers across the whole study pathway.

    Background

    DHSC funds research through NIHR, who work in partnership with the NHS, universities, local government, other research funders, patients and the public to fund, enable and deliver world-leading health and social care research that improves people’s health and wellbeing and promotes economic growth.

    See the NIHR press release for more information.

  • PRESS RELEASE : £267 million to boost local drug and alcohol treatment [November 2023]

    PRESS RELEASE : £267 million to boost local drug and alcohol treatment [November 2023]

    The press release issued by the Department of Health and Social Care on 13 November 2023.

    Every local authority across England to be allocated additional funding to help combat drug and alcohol misuse.

    • Funding will boost treatment, helping to cut crime
    • Part of government’s landmark 10-year drug strategy to improve quality and access of drug and alcohol treatment by reducing drug use to a 30-year low

    Local authorities across England will benefit from almost £267 million of government funding next year to improve drug and alcohol treatment and recovery services.

    The funding, which will be rolled out in April 2024, will enable local authorities to:

    • recruit more specialised staff to work with people with drug and alcohol problems
    • support more prison leavers into treatment and recovery services
    • help reduce crime by increasing the number of people receiving structured drug and alcohol treatment, as well as improving the quality of treatment provided, which in turn helps make streets safer by getting people out of drug use addictions which is known to drive offending

    Health Minister Neil O’Brien said:

    Drug addiction drives about half of all crimes, so by investing in high quality and greater availability of treatment we can reduce crime rates and save lives.

    We aim to raise the number of people getting drug and alcohol treatment to a record high by investing through the long-term investment we’ve been making over the last 3 years.

    Today’s allocations will see £267 million go directly to local authorities and their partners to improve services, increase capacity and quality of treatment and recovery systems, and is based on the recommendations made by Dame Carol Black in her independent review.

    More people will benefit from residential rehabilitation or inpatient detoxification, while improvements to the recovery services will sustain people’s treatment and help to reduce relapse rates.

    This funding is in addition to £95.4 million made available in 2022 to 2023 and £154.3 million for this year – with an overall additional investment of £421 million into drug and alcohol treatment since April 2022.

    From Harm to Hope, published in December 2021, sets out the government’s 10-year ambition to ensure as many people as possible can get the treatment they need by significantly increasing the number of treatment places and recovery services.

    Over the first 3 years of the strategy, the additional investment in treatment and recovery will help prevent nearly 1,000 drug-related deaths – reversing the upward trend in drug deaths for the first time in a decade.

    The strategy also sets out that illegal drug use such as heroin and crack addiction are connected to half of all homicides, and nearly half of all burglaries, robberies and other acquisitive crimes. Dame Carol Black’s independent review of drugs found the best way to tackle this issue is by boosting the capacity of the treatment and recovery system.

    Professor Dame Carol Black, independent adviser to the government on combating drug misuse, said:

    A key aim of my report was to make sure vulnerable people with substance misuse problems can access the support and tools needed to recover and lead full lives.

    Today’s allocations of almost £267 million will go directly to local authorities and their partners, meaning they can deliver treatment that is tailored to meet local needs.

    The end goal is to get many people into world-class recovery and treatment system, reduce drug use and drug related crime – and ultimately save lives.

    Delivering quality treatment provision is core to recovery, and in addition to this significant investment additional grant funding has gone into accommodation and employment support.

    The government’s work to clamp down on criminal gangs profiting from the trade in illegal drugs is backed by £300 million investment (over 3 years). Since the County Lines Programme was launched in 2019, police activity has resulted in over 4,700 lines closed, 14,800 arrests and 7,200 safeguarding referrals.

    Examples of the work supported in 2023 to 2024 include:

    • Lancashire launching a specific service to support women affected by problem alcohol and drug use who are engaged in the criminal justice system. This includes targeted support within police custody suites, enhanced support to help women engage in treatment, and providing safe spaces for women to access mental health support
    • Halton further strengthening its investment in its recovery support services and recovery community, including the expansion of its Recovery Café in Widnes – a service user and volunteer led initiative in Widnes, which supports people in their recovery
    • in Devon, the local authorities expanding their early support response to young people who have been identified with co-occurring substance use and mental ill health through providing a 7 day a week service. Targeted key workers and specialist nurses will provide rapid assessment of young people admitted to hospital and expediate access to alcohol and drug treatment
    • Hartlepool establishing a non-fatal overdose (NFO) team to improve service response to people vulnerable to death. This specialist team proactively engages the community of people identified at higher risk of overdose, as well as accepting referrals for people who have recently experienced an NFO. The team offer brief, intensive interventions aiming to reduce the risk of repeated overdose

    This funding is prioritised for areas with the highest need, based on the rates of drug deaths, deprivation, opiate and crack cocaine prevalence and crime, considering of the size of the treatment population.

    Alice Wiseman, Policy Lead for Addiction at the Association of Directors of Public Health (ADPH), said:

    At a local level, directors of public health and their teams work together with a range of services, including amazing organisations and people from the voluntary and community sector, to deliver effective, life-changing drug and alcohol treatment services.

    As well as supporting people to overcome addiction, the programmes we support really empower people by listening to those with lived experience to shape treatment so that it makes a difference not only to individuals, but to the whole community.

    We know this work is incredibly valuable, both for individuals and communities, but it does require the long-term commitment of this 10-year strategy. The extra funding announced today is very welcome and will enable us to support more people in this way.

    Treatment will be available for a wide range of substances, including heroin, crack, powder cocaine, ecstasy and cannabis – the latter remaining the most common substance (87%) for which young people receive treatment.

    This investment should have clear links to support the plans from Combating Drugs Partnerships on how it will reduce drug-related crime, including improving access and take up of quality treatment for those dependent on opiates and crack cocaine.

    To support this, the government has targeted work across the criminal justice system to increase referrals, including a new police-led referrals into treatment plan, led by the National Police Chiefs’ Council and supported by the Home Office and Department of Health and Social Care.

  • PRESS RELEASE : We must adapt for an ageing population says Chief Medical Officer [November 2023]

    PRESS RELEASE : We must adapt for an ageing population says Chief Medical Officer [November 2023]

    The press release issued by the Department of Health and Social Care on 10 November 2023.

    Professor Chris Whitty’s annual report says we can improve older citizens’ quality of life, and this should be a major aim of policy and medical practice.

    • Successive governments and professional bodies have not recognised the degree to which the population living in older age is concentrating geographically
    • The rise of multiple conditions in the same older person (multimorbidity) requires changes in medical training, NHS services and research

    The fact that people are living longer compared to a century ago is a triumph of medicine and public health but an expansion of the period in ill health is not inevitable.

    England’s Chief Medical Officer (CMO) Professor Chris Whitty, in his annual report published today (10 November 2023) says we need to focus on how to maximise the independence and minimise the time in ill health between reaching older age and the end of life. Quality, enjoyment and independence should be the principal aims.

    The report, Professor Whitty’s fourth as CMO, describes how we can maintain older people’s independence via 2 broad complementary approaches:

    • reduce disease, to prevent, delay or minimise disability and frailty
    • change the environment so that people can maintain their independence longer

    The geography of older age in England is already skewed away from large urban areas towards more rural, coastal and other peripheral areas, and will become more so. Efforts to achieve shorter periods in ill health and an easier environment for those with disabilities should concentrate on areas of the country where the need is going to be greatest.

    The report makes the case that older people are currently underserved in healthcare, with less accessible transport links and insufficient infrastructure designed for older adults, including housing. Providing services and environments suitable for older adults in these areas is an absolute priority if we wish to maximise the period all older citizens have in independence.

    The report calls for research into multimorbidity, frailty and social care to be accelerated, and states that the medical profession needs to focus on maintaining generalist skills as doctors specialise.

    Medical specialisation, specialised NHS provision, National Institute for Health and Care Excellence (NICE) guidelines and medical research are all optimised for single diseases but that is not the lived reality for the great majority of older adults who often transfer very rapidly from having no significant disease states, to several simultaneously. The increasing specialisation of the medical profession runs counter to optimising treatment for this group of largely older citizens and patients.

    Professor Chris Whitty, Chief Medical Officer, said:

    Maximising the quality of health in older adults should be seen as a major national priority – we can make very significant progress with relatively straightforward interventions. Older people can and should be better served.

    We need to recognise and reflect in policy and medical practice where older people are concentrated geographically, increase clinicians’ generalist skills, improve mental health provisions and make it unacceptable to exclude older adults from research because of older age or common comorbidities.

    Greg Fell, President of the Association of Directors of Public Health, said:

    Today’s report from the CMO clearly sets out how important it is that, as a society, we work together to create healthy spaces and places to live and work in. Only by ensuring that people have access to the things that support us to thrive – like good housing, good work and green spaces – can we ensure that people will continue to enjoy good health and wellbeing as they get older.

    Directors of public health and their teams work in partnership with both local authority colleagues and the voluntary and community sector to help create these spaces, with health and wellbeing at their heart, so that as well as living for longer, people are also living healthier, more fulfilling lives.

    Professor Dame Carol Black, Chair of the Centre for Ageing Better, said:

    We welcome the Chief Medical Officer’s new report and its focus on the diversity of experiences in older age. Older generations are repeatedly grouped together as a homogeneous group, when in fact many people are facing enormous challenges and hardship in their later years, as this report makes clear.

    Good health has an enormous influence on people’s enjoyment of later life but we don’t all have an equal opportunity to age well. Wealth, work, housing, discrimination – all play a significant role in the huge gap in healthy life expectancy between the richest and poorest areas of the country.

    We also echo the report’s message that we need to aspire to improve the quality of life for people as they age, including through creating homes and communities that help people to age well. This will not only benefit millions of individuals but also deliver massive societal benefits if more people are given the opportunity to make the most of their later life.

    Professor Dame Linda Partridge, Biological Secretary and Vice President, The Royal Society and Professorial Research Fellow, University College London, said:

    Supporting an ageing population to live well for longer will be a defining challenge of the 21st century, for the UK and many other economies. This timely report from the Chief Medical Officer serves to bring these issues to the forefront of political and public discussion.

    Among the many facets of this challenge, the emerging field of geroscience holds promise for managing and preventing some age-related diseases. Capitalising on this promise will require new treatments and an evolution of approaches across the whole life sciences system, from fundamental discovery to trial design.

    Dr Sarah Clarke, President of the Royal College of Physicians, said:

    With an increasing number of people with multiple long-term conditions, generalist skills are key, as are close working links with primary, community care and the voluntary sector. It is vital that specialists are supported to feel confident in their generalist skills, to provide joined-up care for these patients.

    Professor Adam Gordon, President of the British Geriatrics Society, said:

    Population ageing is one of the biggest opportunities and challenges facing us globally. With this in mind, we welcome that this year the Chief Medical Officer has chosen to focus his annual report on the ageing population. We agree that people living longer lives is a triumph of public health, modern medicine and healthier lifestyles.

    The invaluable contribution of older people to society enriches us all. The Chief Medical Officer is also right to highlight the challenges associated with more people living with complex health and care needs, including increasing levels of frailty and multimorbidity. Inequalities are increasing across our society, with some people enjoying excellent health into their later years and others spending many years living in poor health. There are not enough specialists working in older people’s healthcare and not enough healthcare professionals have developed the right skills to care for this growing population group.

    The Chief Medical Officer’s call to recognise this as a major national priority is very timely – we are all ageing and we must act now to grasp this opportunity, ensuring that older people now and in the future are enabled to live healthy, independent lives for as long as possible.

    Background information

    The CMO’s annual report last year was on air pollution, while his report in 2021 looked at health in coastal communities. The 2020 annual report looked at health trends and variation in England.

    The report demonstrates how the rate of population ageing varies across the country and includes a chapter with contributions from 7 different local authorities:

    • Hampshire County Council
    • Isle of Wight Council
    • Gloucestershire County Council
    • Cumberland Council
    • North Yorkshire Council
    • Derbyshire County Council
    • Norfolk County Council

    For each of these, the director of public health describes the opportunities and challenges of a rapidly ageing population in their local authority.

  • PRESS RELEASE : Government drive to phase out smoking and tackle youth vaping attracts large response [November 2023]

    PRESS RELEASE : Government drive to phase out smoking and tackle youth vaping attracts large response [November 2023]

    The press release issued by the Department of Health and Social Care on 8 November 2023.

    Over 12,000 responses so far submitted on government proposals to create first ‘smokefree generation’, less than halfway through consultation period.

    • Final allocations announced from £70 million a year for local authorities in England to support stop smoking services, helping nearly 360,000 people quit
    • King’s Speech included historic Bill to ban sale of tobacco products to anyone born on or after 1 January 2009, creating a better and brighter future for our children

    Over 12,000 responses have been received as part of the government’s consultation on plans to create a smokefree generation and crack down on youth vaping – the most significant public health intervention in a generation.

    The Prime Minister recently announced plans to introduce a historic new law to stop children who turn 14 this year or younger from ever legally being sold cigarettes in England. He also set out the government’s concerns about the worrying rise in vaping among children and announced a public consultation on plans to reduce the appeal and availability of vapes to children.

    Bolstering efforts to phase out smoking, £70 million has today been allocated by the government for local stop smoking services and support in every local authority in England. This is more than double the current funding available for these services.

    Stop smoking services and support provide one-to-one and group stop smoking sessions, access to accurate information and advice, as well as easy and affordable access to quit aids like skin patches, inhalators, nasal and mouth spray, chewing gum and lozenges.

    Someone quitting before turning 30 could add 10 years to their life and, if a smoker can quit smoking for 28 days, they are five times more likely to quit permanently. This new funding will support around 360,000 people to quit smoking.

    It will be ring-fenced specifically for stop smoking services and the local allocations have been calculated to ensure local authorities with the highest smoking rates receive additional weighted funding.

    Prime Minister Rishi Sunak said:

    I want to build a brighter future for our children, which means taking the necessary decisions for the long-term interests of our country.

    Smoking is a deadly habit, so we are making the biggest single public health intervention in a generation to stop our kids from ever being able to buy a cigarette. This will protect their health both now and in future – saving tens of thousands of lives and saving the NHS billions of pounds.

    Alongside the final funding allocations, the government has issued guidance to local authorities – in partnership with the Local Government Association.

    The guidance highlights how this funding should be used to build capacity in local areas to help more people quit, link smokers to the most effective interventions, and also support existing support schemes like Swap to Stop. The Swap to Stop scheme is the first of its kind in the world and offers a million smokers across England a free vaping starter kit.

    Acknowledging the importance of putting the next generation first and saving lives, on Tuesday 7 November, His Majesty King Charles III set out plans for the government to introduce the Tobacco and Vapes Bill in this parliamentary session.

    Health and Social Care Secretary Steve Barclay said:

    Smoking kills tens of thousands of people every single year. That’s why we’re working at pace to introduce this historic legislation which will protect the next generation, prevent our children from starting smoking, and improve our nation’s health.

    We’ve also announced funding allocations for every single area in England to support local stop smoking services and support, which are proven to significantly improve someone’s chances of quitting for good. The increased new investment of £70 million per year will double current funding for such services and will help save countless lives up and down the country.

    Professor Sir Chris Whitty, Chief Medical Officer for England, said:

    Smoking is highly addictive and causes multiple diseases including heart disease, cancers, dementia and stroke.

    The response to the consultation shows people care strongly about this issue. If passed, the Bill will help ensure the next generation is smoke free and the additional funding will help current smokers stop, preventing major future harm.

    The live public consultation – which closes on Wednesday 6 December – also details proposals to prevent underage and illicit sales of tobacco and vapes, with plans to introduce on the spot fines for underage sales. The consultation is open to anyone, of any age, in the UK to share their experiences and opinions and help shape future policy on vaping and smoking.

    The Health and Social Care Secretary, Steve Barclay, last week visited Salford City Council to meet local councillors, public health leaders, and Trading Standards officers where he discussed work being carried out in the region to seize illicit vapes. He was also shown two shipping containers full of seized products.

    Illicit vapes can contain unknown ingredients, higher levels of nicotine, and are often made easily available to children. Over two million illicit vapes were seized across England by Trading Standards from 2022 to 2023.

    Earlier this year the Prime Minister also announced £30 million to further support agencies such as local trading standards, HMRC and Border Force to take action to stop underage sales and tackle the import of illicit tobacco and vaping products at the border.

    Cllr David Fothergill, Chairman of the Local Government Association’s Community Wellbeing Board said:

    Council cessation services are vitally important in helping smokers to quit. It is good news that they are seeing additional funding which will help to transform the health outcomes of people across the country.

    We believe this is a progressive piece of legislation that would undoubtedly impact on smoking prevalence, and ultimately reduce rates of smoking-related disease.

    The goal of a smokefree generation no longer seems out of reach and we want to work with government and others to achieve this.

    Deborah Arnott, Chief Executive of health charity Action on Smoking and Health (ASH), said:

    ASH congratulates the government for paving the way in the King’s speech for a ground-breaking Bill to create a smokefree generation to be introduced to parliament imminently.

    No parent, whether they smoke themselves or not, wants their children to grow up to become smokers, which is why the smokefree generation policy is so strongly supported by the public.

    We will do all we can, working in lockstep with the health community, to ensure that the legislation is passed before the end of this Parliament.

    Cancer Research UK’s Chief Executive, Michelle Mitchell, said:

    Smoking rates fall with decisive action from leaders: that’s why we support the UK Government’s commitment to changing the age of sale of tobacco announced in the King’s Speech today. We call on MPs from all parties to support the legislation.

    I’ve never met anyone who wants their child to take up smoking. Cancer Research UK estimates that there are around 885,000 16–24-year-olds smoking in the UK today. The recently announced funding can help those smoking to quit, but this proposed legislation could stop the next generation ever becoming addicted to tobacco.

    Sarah Woolnough, Chief Executive at Asthma + Lung UK, said:

    The Bill is historic. Smoking remains the biggest cause of lung disease deaths in the UK. I’m delighted that children today may never legally be able to buy cigarettes and will therefore be protected from developing lung conditions caused by a deadly addiction to tobacco.

    These smokefree plans will free future generations from the pernicious grasp of tobacco addiction, which kills 76,000 people every year. It’s also encouraging to see more than 12,000 responses submitted by the public on the Government’s proposal for a smoke-free generation, making it clear the public care strongly about this issue. And with a recent YouGov survey showing 71% of people support this Bill, there is clearly public backing to create a better and brighter future for our children.

    The government’s approach and commitment to creating the first smokefree generation is extremely welcome, but now it must give this Bill enough time to be passed before the next General Election. With two-thirds smokers saying they started before 18, many of our children face a lifetime trapped in an expensive and deadly addiction if this cycle isn’t broken.

    Proposals being consulted on include:

    • making it an offence for anyone born on or after 1 January 2009 to be sold tobacco products
    • restricting the flavours and descriptions of vapes so that vape flavours are no longer targeted at children – we want to ensure this is done in a way that continues to support adult smokers to switch to vapes
    • regulating point of sale displays in retail outlets so that vapes are kept out of sight from children and away from products that appeal to them, such as sweets
    • considering restricting the sale of disposable vapes, which are clearly linked to the rise in vaping in children. These products are not only attractive to children but also incredibly harmful to the environment
    • regulating vape packaging and product presentation, ensuring that neither the device nor its packaging is targeted to children
    • considering restricting the sale of disposable vapes, which are clearly linked to the rise in vaping in children. These products are not only attractive to children but also incredibly harmful to the environment
    • exploring further restrictions for non-nicotine vapes and other nicotine consumer products such as nicotine pouches exploring whether increasing the price of vapes will reduce the number of young people using them
    • introducing new powers for local authorities to issue on-the-spot fines (fixed penalty notices) to enforce age of sale legislation of tobacco products and vapes
  • PRESS RELEASE : Funding for non NHS-organisations for one-off payments [November 2023]

    PRESS RELEASE : Funding for non NHS-organisations for one-off payments [November 2023]

    The press release issued by the Department of Health and Social Care on 6 November 2023.

    Eligible non-NHS organisations including charities and social enterprises can apply for funding to deliver one-off payments to staff, worth at least £1,655.

    • Payments were agreed as part of NHS pay award between government and unions which also gave over one million staff a 5% pay rise in 2023 to 2024
    • Government has stepped in to help independent organisations deliver the payments, on this occasion

    Eligible healthcare staff at non-NHS organisations such as charities, local authorities or social enterprises will benefit from government funding to cover the cost of their one-off payments as part of the NHS pay award, worth at least £1,655.

    It comes after the NHS pay deal, agreed between government and unions in May, saw over one million staff including nurses, paramedics and 999 call handlers receive a 5% pay rise for 2023 to 2024, backdated to April, alongside two one-off payments worth between £1,655 and £3,789 for full-time staff.

    The government has agreed to provide additional funding for organisations with contracts to deliver NHS services, who employ their staff on dynamically linked Agenda for Change contracts. Whilst these staff are contractually eligible for the payments, the independent organisations are responsible for making them.

    The department has however listened to concerns around providing the payments in the current economic circumstances and so will make funding available to help deliver them, on this occasion.

    Health Minister Will Quince said:

    Given the difficult economic context we have made the decision to provide additional funding on this occasion to help deliver the one-off payments to eligible staff employed by non-NHS organisations. This will ensure hardworking healthcare staff and the organisations they work for are not financially disadvantaged as a result of the NHS pay deal, and means they will receive their backlog bonus for their efforts during the pandemic.

    Organisations will be able to apply for the funding and will need to show they have been negatively financially impacted by the pay deal, and that their staff are employed on dynamically linked Agenda for Change contracts.

    Many organisations have already delivered the one-off payments to staff but can apply to be reimbursed to ensure there is no impact on vital frontline services.

    The scheme, which will be funded from existing departmental budgets, will open in the coming weeks, and is expected to be completed by the end of the 2023 to 2024 financial year.

    As a result of the pay award, a newly qualified nurse has seen their salary go up by more than £2,750 over two years from 2021 to 2022 and 2023 to 2024, alongside over £1,890 in one-off payments this year.

    Non-NHS organisations commissioned by the NHS have, where eligible, already been funded for the consolidated 5% uplift under the terms of existing contracts.

    Background information

    Dynamically linked contracts are kept in line with the national Agenda for Change contract, so they automatically reflect any changes/uplifts.

    The NHS pay deal, agreed by NHS Staff Council in May, included two non-consolidated pay awards for 2022 to 2023. These non-consolidated payments covered staff directly employed by NHS organisations (for example, permanent and fixed term contracts) as set out in Annex 1 of the handbook on Agenda for Change terms on 31 March 2023. However, some staff in non-Annex 1 organisations are contractually entitled to the payments, and therefore their employers were responsible for making these payments.

    The Department cannot confirm the costs of this scheme until all applications have been received and assessed in line with the criteria and guidance set out by NHS England.

  • PRESS RELEASE : Government to deliver 160 community diagnostic centres a year early [November 2023]

    PRESS RELEASE : Government to deliver 160 community diagnostic centres a year early [November 2023]

    The press release issued by the Department of Health and Social Care on 1 November 2023.

    The community diagnostic centre (CDC) programme is largest central cash investment in MRI and CT scanning capacity in the history of the NHS.

    • The government has announced 3 of the final CDC locations which will serve tens of thousands of patients in London, Sussex and Yorkshire – offering patients greater choice on where and how they are treated
    • Over 5 million tests, checks and scans have been delivered for patients so far, as part of efforts to bring down waiting lists

    The government will meet its target to open 160 community diagnostic centres a year early, the Health and Social Care Secretary will announce today (31 October 2023).

    All 160 centres will be open by March 2024, a year ahead of the original March 2025 target – speeding up access to potentially lifesaving tests and checks.

    In a speech to the Independent Healthcare Providers Network, he will confirm the rollout of the one-stop shops following the hard work of NHS staff and the government’s efforts to maximise use of the independent sector – backed by the £2.3 billion in capital funding.

    Based in a variety of settings including shopping centres, university campuses and football stadiums, 127 of the community healthcare hubs are already open – including 40 brought forward earlier than planned. They offer patients a wide range of diagnostic tests closer to home and greater choice on where and how they are treated, reducing the need for hospital visits and helping them to receive potentially life-saving care sooner.

    The programme constitutes the largest central cash investment in MRI and CT scanning capacity in the history of the NHS and has already delivered more than 5 million additional tests, checks and scans across the country. The new centres will provide capacity for 9 million more by 2025 as part of the NHS and government’s plan to recover services following the pandemic.

    Health and Social Care Secretary Steve Barclay said:

    Patients deserve the highest quality care, and community diagnostic centres have been instrumental in speeding up the diagnosis of illnesses like cancer and heart disease to ensure patients are treated more quickly.

    I’m delighted we will open 160 CDCs a year early, allowing greater access to high tech scans and diagnostics in communities across England.

    This has been made possible by using all capacity available to us and drawing on the independent sector – helping us to cut waiting lists, one of the government’s top 5 priorities.

    The government has announced 3 of the final locations which will serve tens of thousands of patients, with all set to open in December 2023. They are:

    • Queen Mary’s Sidcup CDC – based in south-east London, the facility will offer CT, MRI and ultrasound checks, along with blood tests – providing at least 58,000 additional checks once fully operational
    • Halifax CDC – based at Broad Street Plaza shopping centre in the Yorkshire town, this CDC will offer ultrasound checks, blood tests and heart scans – delivering at least 90,000 tests once fully operational
    • Chichester University CDC, Bognor Regis – this facility will offer CT and MRI scans along with ultrasound checks and blood tests to patients, and deliver at least 18,000 additional tests once fully operational

    In total, 13 of the CDCs are led by the independent sector, with 8 of these already operational. There are a further 22 CDCs located on the NHS estate where the independent sector is providing diagnostic services. They function like NHS-run CDCs but by making use of the available capacity in the independent sector patients can access additional diagnostic capacity free at the point of need.

    Alongside this, as the Prime Minister originally announced in May, hundreds of thousands of NHS patients who have been waiting longer than 40 weeks for treatment will today be offered the opportunity to travel to a different hospital as part of ambitious measures set out in the elective recovery plan.

    Any patient who has been waiting longer than 40 weeks and does not have an appointment within the next 8 weeks will be contacted by their hospital via letter, text or email. The 400,000 eligible patients will then be able to submit their details, including how far they are willing to travel.

    Thanks to this and wider measures, the government successfully met the first target in its elective recovery plan to virtually eliminate waits of over 2 years and has cut 18-month waits by over 90% from the peak in September 2021.

    Earlier this year, the government’s Elective Recovery Taskforce set out a plan to maximise independent sector capacity to treat NHS patients more quickly. Chaired by Health Minister Will Quince and made up of academics and experts from the NHS and independent sector, the taskforce looked for ways to go further to bust the COVID-19 backlogs and reduce waiting times for patients.

    Its recommendations will ensure patients have the right to receive care at a provider of their choice, encourage the system to work together to deliver a post-pandemic recovery, and monitor the contribution of the independent sector to delivering health services and developing the workforce.

    Earlier this month, the government also invested £200 million to boost resilience in the NHS and help patients get the care they need as quickly as possible this winter. The new funding came after the Prime Minister and Health and Social Care Secretary met clinical leaders and NHS chiefs to drive forward planning to ease pressures in urgent and emergency care while protecting waiting list targets this winter. Alongside this, £40 million was invested to bolster social care capacity and improve discharge from hospital.

    Background information

    DHSC and NHS England count CDCs delivering tests and accessing national funding as open. This may include temporary sites while the full CDC is completed.

    We are now recruiting for an independent chair of the choice panel, who will help promote compliance with rules on patient choice.

    In September, NHS England confirmed that 4 other CDCs had been approved – 2 in Wiltshire, one in Thanet and one in Cheshire.

    The full list of open CDCs can be found below:

    • Andover CDC
    • Barking Community Hospital CDC
    • Barnsley Glassworks CDC
    • Bexhill CDC
    • Bishop Auckland CDC
    • Blaydon CDC
    • Bolton CDC
    • Bradford District and Craven CDC
    • Bath Somerset and Wiltshire Banes Locality CDC
    • Buckland Community Hospital CDC
    • Cannock Chase CDC
    • CDC Poole @Dorset Health Village with spoke CDCs:
      • Poole, Beales CDC
      • South Walks CDC
      • Boscombe AECC CDC
      • Weymouth CDC
    • CIOS Bodmin CDC with spoke CDC:
      • West Cornwall CDC
    • Clacton CDC
    • Clatterbridge Diagnostics CDC with spoke CDCs:
      • Ellesmere Port CDC
      • Liverpool Women’s Hospital CDC
    • Paddington CDC
    • Corbett CDC with spoke CDCs:
      • Guest CDC
      • Merry Hill CDC
    • Corby CDC with spoke CDC:
      • Kings Heath CDC
    • Coventry City Community CDC with spoke CDC:
      • Rugby St Cross CDC
    • Crawley Collaborative CDC with spoke CDC:
      • Caterham Dene CDC
    • Devon Exeter Nightingale CDC
    • East Somerset CDC
    • Eltham Community Hospital CDC
    • [Ely CDC (hub) – not open yet] with spoke CDC:
      • Wisbech CDC
    • Finchley Memorial Hospital CDC with spoke CDC:
      • Wood Green CDC
    • Florence Nightingale Community Hospital CDC with spoke CDC:
      • Sir Robert Peel CDC
    • Gloucestershire Quayside CDC
    • Grantham CDC
    • Hereford City CDC with spoke CDC:
      • Kidderminster Treatment Centre CDC
    • Hinckley CDC
    • Huddersfield CDC
    • Ilkeston Community Hospital CDC with spoke CDC:
      • Whitworth Hospital CDC
    • Island CDC
    • [James Paget CDC – not open yet] with spoke CDC:
      • East Norfolk CDC
    • Leeds CDC with spoke CDC:
      • Armley Moor Health Centre CDC
    • Leicester CDC
    • Leigh CDC
    • Lymington New Forest Hospital CDC with spoke CDCs:
      • Hythe CDC
      • Romsey CDC
    • Manchester and Trafford CDC
    • Mansfield CDC
    • Mile End Hospital CDC
    • Milford Community Hospital CDC
    • Montagu Hospital CDC with spoke CDC:
      • Rotherham Diagnostics CDC
    • New QEII Hospital CDC
    • [North Bedfordshire CDC (hub) – not open yet] with spoke CDC:
      • Whitehouse Health Centre CDC
    • North Bristol CDC
    • [North Lincolnshire CDC (hub) – not open yet] with spoke CDCs:
      • Askham Bar Community Care Centre CDC
      • East Riding Community Hospital CDC
      • Selby War Memorial CDC
    • North Solihull CDC
    • Northern Care Alliance Oldham CDC with spoke CDC:
      • Salford CDC
    • [NWL Ealing CDC (hub) – not open yet] with spoke CDC:
      • Wembley CDC
      • Willesden CDC
    • Oxford CDC
    • Penrith CDC
    • Portsmouth CDC with spoke CDC:
      • Fareham CDC
      • Oak Park CDC
    • Preston Healthport CDC
    • Queen Mary’s Hospital Roehampton CDC with spoke CDCs:
      • Kingston CDC
      • Purley CDC
    • Queen Victoria Hospital CDC
    • Rossendale CDC with spoke CDC:
      • Burnley General Hospital Spoke CDC
    • Royal South Hants CDC
    • [Slough CDC (hub) not open yet] with spoke CDC:
      • Heatherwood CDC
    • Somerset West CDC with spoke CDCs:
      • Bridgwater CDC
      • South Petherton CDC
      • Taunton Central CDC
      • West Mendip CDC
      • Yeovil CDC
    • South Warwickshire CDC
    • Southlands Hospital CDC with spoke CDCs:
      • Bognor Regis WMH CDC
    • Brighton CDC
    • St Helens CDC with spoke CDC:
      • Southport CDC
    • Shrewsbury Telford and Wrekin CDC
    • Swale CDC with spoke CDC:
      • Medway CDC
    • [Tees Valley CDC – not yet open] with spoke CDCs:
      • Lawson Street CDC
      • Friarage CDC
      • Hartlepool CDC
      • Redcar CDC
    • Thurrock CDC with spoke CDC:
      • Braintree CDC
    • Victoria Infirmary Northwich CDC
    • Warrington and Halton CDC with spoke CDC:
      • Shopping City CDC
    • Warwickshire North CDC
    • Washwood Heath CDC
    • West Berkshire Community Hospital CDC with spoke CDCs:
      • Amersham CDC
      • Bracknell CDC
    • West Essex CDC with spoke CDC:
      • Bishop’s Stortford CDC
    • West Kent CDC
    • Westmorland CDC with spoke CDCs:
      • Crossland Day Hospital CDC
      • Heysham CDC
    • Weston CDC
    • Whitegate Drive CDC with spoke CDC:
      • Fleetwood CDC
    • Woking Community Hospital CDC
  • PRESS RELEASE : AI to speed up lung cancer diagnosis deployed in NHS hospitals [October 2023]

    PRESS RELEASE : AI to speed up lung cancer diagnosis deployed in NHS hospitals [October 2023]

    The press release issued by the Department of Health and Social Care on 30 October 2023.

    £21 million is being allocated to 64 NHS trusts across England to roll out AI tools to speed up the diagnosis and treatment of lung cancer.

    • AI tools to help NHS staff analyse X-rays and CT scans expected to be in place by winter, increasing efficiency and cutting waiting times
    • Health and Social Care Secretary hosts AI roundtable with industry leaders to drive forward innovation in health and social care

    Ground-breaking artificial intelligence (AI) that can help clinicians diagnose lung cancer quickly and accurately is being rolled out in NHS hospitals across England following a £21 million funding boost from the government.

    The funding is being allocated to 64 NHS trusts across all regions of the country so they can deploy AI tools that analyse X-rays and CT scans, speeding up diagnosis and treatments for patients.

    With over 600,000 chest X-rays performed each month in England, the deployment of this technology to more NHS trusts will support clinicians in their work with quicker, more accurate diagnosis of conditions.

    The new tools will start being deployed in NHS hospitals for winter, which will help to ease pressures on the NHS and free up staff time.

    The Health and Social Care Secretary hosted a roundtable with NHS trusts, industry leaders and health officials today (30 October 2023) to identify ways of speeding up the roll out of AI in health and social care.

    Discussions focused on the safe deployment of AI to help cut waiting lists and relieve pressure on hospitals, free up staff time by automating admin tasks, and support people in care settings to live more independently.

    Health and Social Care Secretary Steve Barclay said:

    We are rolling out more cutting-edge AI technology across the NHS to help with quicker, more accurate diagnosis of lung cancer because patients deserve the best care possible.

    AI is already being used in the NHS to halve treatment times for stroke patients and to assist doctors in analysing brain scans, reducing the time between admission and treatment by more than one hour – saving valuable staff time and improving patient recovery.

    We’re building on this success to make sure lung cancer patients get the support they need, when they need it.

    Dr Vin Diwakar, national director of transformation at NHS England, said:

    Artificial intelligence is already helping to save lives from faster diagnosis of a stroke allowing faster emergency treatment to providing patients with their personalised risk of a heart attack allowing their clinicians to intervene earlier.

    This investment will allow 64 NHS trusts from across the country to harness the power of AI to tools to speed up the diagnosis and treatment of lung cancer.

    The use of AI in the NHS is already having a positive impact on outcomes for patients. AI tools are now live in over 90% of stroke networks in England – halving the time for stroke victims to get treatment in some cases, helping to cut waiting times.

    For example, Brainomix e-Stroke uses AI to analyse brain scans of people who have had strokes to assist doctors with diagnosis and treatment decisions. Early studies have shown Brainomix can reduce the time between a patient arriving at hospital after they’ve had a stroke, to receiving treatment by more than one hour through providing instant interpretations of brain scans to help guide treatment and transfer decisions for stroke patients faster. The studies also showed it can triple the number of people achieving functional independence after having a stroke, from 16% to 48%, through allowing more patients to get the right treatment, in the right place, at the right time.

    The roundtable, held at the Department of Health and Social Care, also focused on the importance of safely deploying AI across the health and care system, placing emphasis on regulation and ethics.

    AI has the potential to transform patient care in the NHS, but does not always lend itself to traditional methods of demonstrating evidence for effectiveness. The Medicines and Healthcare products Regulatory Agency is rolling out a world-leading partnership between government, regulators and industry which will see advanced AI technology used in NHS settings safely ahead of regulatory approval – allowing NHS patients to benefit earlier from emerging technology before it is available anywhere else in the world.

    This system, known as AI-Airlock, will open for products in April 2024 and will allow innovators to test the technology in NHS settings, helping to generate data quickly on its effectiveness. This will prioritise patient safety while encouraging innovation at pace within the industry – meaning there is no delay in patients benefiting from potentially lifesaving technology between regulatory approval and deployment.

    Alongside this, a team at the University Hospitals Birmingham NHS Foundation Trust and University of Birmingham has released new international standards, supported by the NHS AI Lab and The Health Foundation, to ensure AI systems are developed using diverse and inclusive datasets that can benefit all demographic groups. The team worked with over 350 stakeholders from more than 58 countries to build recommendations on how data should be recorded and used for AI, helping to boost transparency and address any potential biases.

    The government has already invested £123 million into 86 AI technologies, which is helping patients by supporting stroke diagnosis, screening, cardiovascular monitoring and managing conditions at home.

    Background information

    The following trusts are receiving a share of the £21 million funding:

    • East and North Hertfordshire NHS Trust
    • West Hertfordshire Teaching Hospitals NHS Trust
    • Royal Papworth Hospital NHS Foundation Trust
    • James Paget University Hospitals NHS Foundation Trust
    • The Queen Elizabeth Hospital, King’s Lynn, NHS Foundation Trust
    • West Suffolk NHS Foundation Trust
    • North West Anglia NHS Foundation Trust
    • Bedfordshire Hospitals NHS Foundation Trust
    • East Suffolk and North Essex NHS Foundation Trust
    • Mid and South Essex NHS Foundation Trust
    • Norfolk and Norwich University Hospitals NHS Foundation Trust
    • Cambridge University Hospitals NHS Foundation Trust
    • London North West University Healthcare NHS Trust
    • The Hillingdon Hospitals NHS Foundation Trust
    • Chelsea and Westminster Hospital NHS Foundation Trust
    • Imperial College Healthcare NHS Trust
    • Barts Health NHS Trust
    • Barking, Havering and Redbridge University Hospitals NHS Trust
    • Homerton Healthcare NHS Foundation Trust
    • Chesterfield Royal Hospital NHS Foundation Trust
    • Kettering General Hospital NHS Foundation Trust
    • Northamptonshire Healthcare NHS Foundation Trust
    • Nottingham University Hospitals NHS Trust
    • Sherwood Forest Hospitals NHS Foundation Trust
    • Lincolnshire Partnership NHS Foundation Trust
    • University Hospitals of Leicester NHS Trust
    • Hull University Teaching Hospitals NHS Trust
    • York and Scarborough Teaching Hospitals NHS Foundation Trust
    • Northern Lincolnshire and Goole NHS Foundation Trust
    • County Durham and Darlington NHS Foundation Trust
    • Gateshead Health NHS Foundation Trust
    • North Cumbria Integrated Care NHS Foundation Trust
    • North Tees and Hartlepool NHS Foundation Trust
    • Northumbria Healthcare NHS Foundation Trust
    • South Tyneside and Sunderland NHS Foundation Trust
    • South Tees Hospitals NHS Foundation Trust
    • Bolton NHS Foundation Trust
    • Manchester University NHS Foundation Trust
    • Northern Care Alliance NHS Foundation Trust
    • Tameside and Glossop Integrated Care NHS Foundation Trust
    • The Christie NHS Foundation Trust
    • Stockport NHS Foundation Trust
    • Wrightington, Wigan and Leigh NHS Foundation Trust
    • The Clatterbridge Cancer Centre NHS Foundation Trust
    • Countess Of Chester Hospital NHS Foundation Trust
    • East Cheshire NHS Trust
    • Mid Cheshire Hospitals NHS Foundation Trust
    • Liverpool Heart and Chest Hospital NHS Foundation Trust
    • Liverpool University Hospitals NHS Foundation Trust
    • Warrington and Halton Teaching Hospitals NHS Foundation Trust
    • Liverpool Women’s NHS Foundation Trust
    • Wirral University Teaching Hospital NHS Foundation Trust
    • Mersey and West Lancashire Teaching Hospitals NHS Trust
    • University Hospitals Plymouth NHS Trust
    • Royal Devon University Healthcare NHS Foundation Trust
    • Royal Cornwall Hospitals NHS Trust
    • Torbay and South Devon NHS Foundation Trust
    • University Hospitals Sussex
    • Ashford and St Peter’s Hospitals NHS Foundation Trust
    • East Sussex Healthcare NHS Trust
    • Royal Surrey County Hospital NHS Foundation Trust
    • Queen Victoria Hospital NHS Foundation Trust
    • Surrey and Sussex Healthcare NHS Trust
    • Frimley Health NHS Foundation Trust

    For more information on innovation used in the NHS, visit our media blog: how we are delivering innovation in health and social care services.

    The Health and Social Care Secretary announced the £21 million funding in June this year. The money is now being allocated to NHS trusts.